Evidence map›Paper›PMID 32313876›Full record

ArticleConditioning medicine2019

Chronic remote ischemic conditioning for cardiovascular protection.

Jun Chong, Heerajnarain Bulluck, Andrew Fw Ho, William A Boisvert, Derek J Hausenloy

Open access · greenAbstract read
In one paragraph

Article in Conditioning medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. mBioengineered · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Jun ChongBarts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Heerajnarain BulluckNational Heart Centre Singapore, Singapore.
Andrew Fw HoCardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore.
William A BoisvertCenter for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii, USA.
Derek J HausenloyNational Heart Centre Singapore, Singapore.
National University of Singapore · SGKazan Federal University · RUNational Institute for Health Research · GBNorfolk and Norwich University Hospital · GB

Funding

The Role of gp120 on Cardiovascular Disease in People Living with HIVU54MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI Gehan Devendra · 2017 to 2026
$59.5M
Rho kinase in immune-mediated atherosclerosisR01HL081863 · NHLBI · UNIVERSITY OF HAWAII AT MANOA · PI BOISVERT, WILLIAM A · 2007 to 2010
$1.6M
NHLBI NIH HHS R01 HL081863NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

New treatments are needed to prevent adverse left ventricular remodelling following acute myocardial infarction (AMI), in order to prevent heart failure and improve clinical outcomes following AMI. Remote ischemic conditioning (RIC) using transient limb ischemia and reperfusion has been reported to reduce myocardial infarct (MI) size in AMI patients treated by primary percutaneous coronary intervention, and whether it can improve clinical outcomes is currently being investigated. Interestingly, repeated daily episode of limb RIC (termed 'chronic remote ischemic conditioning', or CRIC) has been shown in experimental and clinical studies to confer beneficial effects on post-AMI cardiac remodelling and chronic heart failure. In addition, the beneficial effects of CRIC extend to vascular function, peripheral arterial disease and stroke. In this review article, we focus on the therapeutic potential of CRIC as a strategy for cardiovascular protection and for improving clinical outcomes in patients with cardiovascular disease.

Identifiers

PMID32313876
PMCPMC7169952
OpenAlexW3025614095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.